What is Aspirin?
Aspirin is a novel technology that aims to reduce pain in conditions including migraines, cluster headache and other head and facial pain. Moreover, Aspirin is the most popular brand available for a headache across the world. In 2016, according to the World Health Organization (WHO), a prevalence of a headache among adults is about 50%. On the other hand, it is estimated that nearly 700 to 1000 clinical trials are conducted every year for aspirin to find its additional usage.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Bayer (Germany), Novacap (Canada), Shiono Chemical Co. (Japan), Chemische Fabrik Weyl Gmbh (Germany), Eli Lilly And Co (United States), Industria Quimica Andina Y Cia Sa (Colombia), Jqc Huayin Pharmaceutical Co Ltd (China), Lohmann Lts (Germany), Novacyl Sas (France), Upjohn Co (United States), Shandong Xinhua Pharmaceutical Co Ltd (China), The Andhra Sugars Ltd (India), Dow Chemical Co (United States), Alfred Benzon As (Denmark), Eurand America Inc (United States), Industries Monfel S.A. De C.V. (Mexico), Nanjing Pharmaceutical Factory (China) and Jilin Pharmaceutical (United States) |
The study covers a detailed analysis segmented by key business segments i.e. by type (99.5% Purity, 99% Purity and Others) , by application (Tablets Product, Capsule Product and Others) and major geographies. Research Analyst at AMA predicts that Chinese, United States Players will contribute to the maximum growth of Global Aspirin market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Aspirin market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are Bayer (Germany), Novacap (Canada), Shiono Chemical Co. (Japan), Chemische Fabrik Weyl Gmbh (Germany), Eli Lilly And Co (United States), Industria Quimica Andina Y Cia Sa (Colombia), Jqc Huayin Pharmaceutical Co Ltd (China), Lohmann Lts (Germany), Novacyl Sas (France), Upjohn Co (United States), Shandong Xinhua Pharmaceutical Co Ltd (China), The Andhra Sugars Ltd (India), Dow Chemical Co (United States), Alfred Benzon As (Denmark), Eurand America Inc (United States), Industries Monfel S.A. De C.V. (Mexico), Nanjing Pharmaceutical Factory (China) and Jilin Pharmaceutical (United States).
Market Overview:
In January 2021, Eli Lilly and Company acquired Prevail Therapeutics Inc. This acquisition establishes a new modality for drug discovery and development at Lilly and expands Lilly's research efforts through the creation of gene therapy programs that will build on Prevail's portfolio of clinical-stage and pre-clinical neuroscience assets.
Of late, Autonomic Technologies Inc (ATI) is investing in the development of electronic aspirin. The company is mainly focusing on the development of new therapies for the treatment of cluster headaches. For instance, in March 2017, ATI received an expanded indication (CE mark) in Europe for the Pulsante SPG Microstimulator system to include pain relief for highly affected migraine patients.
Influencing Trend:
Surging use of electronic aspirin
Market Growth Drivers:
Increasing headache, stress-related work and rise in demand for advanced medical device and The surging number of cigarette consumers
Challenges:
Lack of awareness among people in underdeveloped nations
Restraints:
Stringent regulation for medical devices and lack of clinical data
Opportunities:
An increasing future expectation for electronic aspirin
Key highlights of the Global Aspirin market Study:
CAGR of the market during the forecast period 2022-2028
In-depth information on growth factors that will accelerate the Aspirin market in next few years.
Detailed Insights on futuristic trends and changing consumer behavior
Forecast of the Global Aspirin market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Aspirin Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Aspirin market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Aspirin market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Manufacturer / Potential Investors, Traders, Distributors, Wholesalers, Retailers, Importers and Exporters. and Association and government bodies.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.